Stripe Closed My Telehealth Account: What to Do Next

If Stripe closed your telehealth account, treat it as a contract, underwriting, risk, fraud, dispute, security, or acquiring-relationship decision, not as a federal finding that the business is unlawful. Because the approved sources do not establish a universal notice period, reserve-release schedule, or right to continued processing, start by preserving records and requesting the written basis for the action from Stripe.

Telehealth merchant account closed: immediate priorities

Why do processors like Stripe close telehealth accounts?

Because telehealth and compounded-medication businesses are card-not-present, subscription-heavy, and health-regulated, and general-purpose processors underwrite them as elevated risk. The closure notice itself is the only authoritative statement of the reason, so request it in writing. The triggers that show up most often are the ones the federal sources in this guide regulate: recurring-billing and cancellation practices under the FTC's rules, advertising claims about prescription products, protected health information reaching a system that is not covered by a business associate agreement, dispute and refund ratios, and licensing or registration questions in the states you serve. Stripe's own terms, restricted-business list, and reserve rules are not part of the approved source pool for this guide, so this article does not restate them; read them directly and compare them to your notice.

What to request from the processor or acquirer

Send a written request asking for:

• The contractual provision supporting the action.
• The effective termination, suspension, or restriction date.
• The amount and calculation of any reserve or withheld balance.
• The applicable process for releasing funds, if one exists.
• The treatment of pending transactions, refunds, chargebacks, retrieval requests, and recurring transactions.
• Any appeal, remediation, or re-underwriting process.
• The category of concern, such as disputes, inaccurate underwriting information, marketing claims, prohibited activity, licensing, or data security.

Treat this as a business-risk response, not as a guaranteed legal right to an explanation or appeal. Card-network thresholds, monitoring triggers, fees, reserve percentages, and release schedules were not established in the approved research. Request current figures and rules directly from the acquirer rather than relying on generalized internet claims.

Protect refunds, subscriptions, and customer communications

First reconcile open orders, refunds, subscriptions, failed payments, and support obligations. Do not change material billing terms without appropriate disclosure, obscure the merchant of record, or bypass legitimate fraud and underwriting controls.

For online negative-option transactions, the Restore Online Shoppers’ Confidence Act, 15 U.S.C. §§ 8401–8405, and FTC guidance address clear and conspicuous material-term disclosures, express informed consent before charging, and a simple way to stop recurring charges. Review enrollment records, price and renewal language, cancellation handling, and refund procedures.

The FTC’s 2024 amended Negative Option Rule should not be presented as a current operative requirement: FTC materials state that it was vacated by the U.S. Court of Appeals for the Eighth Circuit in July 2025. The FTC opened a new advance notice of proposed rulemaking in March 2026. Confirm the current legal position with qualified counsel.

Any continued processing depends on the processor or acquirer, the account status, the contract, and applicable billing requirements. Do not assume that a new account or workaround permits continued recurring charges.

Audit the business before reapplying

A replacement application should accurately describe the real operating model. Review:

• Memberships, subscriptions, consultations, products, and medication-related activities, if any.
• Payment timing, average and highest transaction values, recurring-billing share, refunds, and dispute history.
• Advertising claims, testimonials, reviews, insurance or savings statements, and cancellation promises.
• Licenses, registrations, clinicians, pharmacies, fulfillment partners, payment facilitators, domains, and states served.
• Whether vendors receive protected health information, identifiable health information, consumer health data, or only payment tokens and transaction amounts.
• Privacy policies, business-associate agreements where applicable, data-flow diagrams, access controls, and incident records.

Section 5 of the FTC Act, 15 U.S.C. § 45, prohibits deceptive acts or practices. The FTC Endorsement Guides, 16 C.F.R. Part 255, address material connections, misleading endorsements, and substantiation. The Consumer Reviews and Testimonials Rule, 16 C.F.R. Part 465, addresses fake or false reviews, sentiment-conditioned reviews, undisclosed insider reviews, deceptive review suppression, and fake social-media indicators.

Audit universal or guaranteed outcome claims, testimonials implying typical results, paid reviews, undisclosed relationships, and claims that a subscription can be canceled at any time if that is not operationally true.

HIPAA may also be relevant. The Privacy Rule, 45 C.F.R. Part 164, Subpart E, and Security Rule, 45 C.F.R. Part 164, Subpart C, apply to covered entities and business associates in applicable circumstances. Payment-related uses do not eliminate privacy or security duties. The HIPAA Breach Notification Rule, 45 C.F.R. §§ 164.400–414, generally requires notice without unreasonable delay and no later than 60 days after discovery for covered breaches; a business associate must notify the covered entity within the applicable timeframe.

The FTC Health Breach Notification Rule, 16 C.F.R. Part 318, may apply to certain health apps, personal health record vendors, related entities, and service providers outside HIPAA. The FTC Safeguards Rule, 16 C.F.R. Part 314, does not automatically apply to every healthcare provider; determine first whether the business is a covered FTC-regulated financial institution. FTC security guidance recommends taking stock of sensitive information, securing web applications, encrypting data in transit and where appropriate at rest, and managing service-provider security responsibilities.

Clinical decisions belong to independently licensed clinicians. Payment review does not replace clinical, privacy, regulatory, or state-specific review.

Build an accurate replacement underwriting package

Include:

1. 1The services actually provided and all relevant domains.
2. 2Membership, subscription, consultation, product, and medication-related workflows.
3. 3Payment timing, transaction values, recurring-billing percentage, refunds, and dispute history.
4. 4States served, licenses, registrations, clinicians, pharmacies, fulfillment partners, and payment vendors.
5. 5Patient-facing consent, cancellation, refund, privacy, and security documentation.
6. 6A technology map showing where payment information, PHI, or consumer health data travels.
7. 7A concise explanation of the closure and corrective actions taken.

Never relabel telehealth, subscription, or medication-related activity to obtain approval. An inaccurate disclosure can create a separate contractual and fraud-risk problem.

State-specific issues require separate review

A federal overview cannot establish rules for every state. Obtain state-specific review for:

• Telehealth licensure and the location of clinicians and patients.
• Pharmacy, medication-sales, and establishment requirements.
• Automatic-renewal and subscription disclosures, cancellation, and refund rules.
• Health-data privacy and breach notification.
• Professional-board advertising, testimonial, fee-splitting, and referral standards.
• Contract remedies, reserve funds, and potential unclaimed-property issues.

Do not infer a state rule from another state or assume that federal telehealth billing guidance guarantees private payment-processing access. CMS billing materials concern eligibility, services, practitioners, locations, and claims—not whether an acquirer must continue processing cards.

Recommended response sequence

1. 1Founder: Save the notice, agreement, application, statements, dispute and refund reports, reserve correspondence, and customer billing records.
2. 2Processor or acquirer: Request the contractual basis, status, effective date, funds treatment, and any review process in writing.
3. 3Finance and operations: Reconcile refunds, subscriptions, failed payments, payroll exposure, and support obligations.
4. 4Platform and compliance teams: Map payment, billing, clinical, fulfillment, pharmacy, and data flows.
5. 5Compliance reviewers: Audit recurring consent, cancellation, advertising, testimonials, reviews, privacy, security, and breach-response procedures.
6. 6State reviewers or counsel: Check applicable licensure, pharmacy, privacy, automatic-renewal, breach, and professional-board requirements.
7. 7Founder: Submit an accurate underwriting package explaining the model, closure, disputes, licenses, vendors, and corrective actions.

MDLaunchr, the brand behind WhiteLabelClinic.com, is a white-label telehealth infrastructure platform—not a processor, regulator, law firm, or guarantor of reinstatement. Request an emergency processing review to explore how MDLaunchr and WhiteLabelClinic.com can support a compliance-first telehealth launch. Any processor or acquirer makes its own underwriting decision.

Frequently asked questions

Is a closed telehealth merchant account permanent?

Not necessarily. The agreement may make the closure final, or the processor may offer review, remediation, or re-underwriting. The available path and reserve treatment are contract- and processor-specific.

Does closure mean the telehealth business is illegal?

No. Closure is not automatically a federal clinical or licensing determination. Separate advertising, billing, privacy, security, and state-law issues may still require correction.

Can I open another payment account immediately?

You can apply, but first identify the closure reason and prepare accurate disclosures, dispute records, licenses, billing controls, and security documentation. Do not conceal the prior closure or change the business description.

Can I keep charging recurring customers after closure?

Not through an undisclosed workaround or a process that changes material billing terms. Whether any recurring transactions can continue depends on the processor or acquirer, the account status, the contract, and applicable billing requirements. Review consent, renewal disclosures, cancellation, and refunds first.

What records should I gather?

Collect the closure notice, agreement, application, statements, chargeback and refund reports, reserve communications, customer billing records, licenses, privacy and security policies, vendor agreements, and data-flow information.

Can MDLaunchr reopen my account?

No. MDLaunchr is not a processor and cannot guarantee reinstatement, approval, fund recovery, reserve release, or processing availability. It can help qualified businesses organize infrastructure, operational, compliance, clinical-network, and fulfillment questions for review.

Related reading: the full guide this article belongs to, How Chargebacks Affect Telehealth Merchant Accounts, How Underwriters Evaluate a Telehealth Website Before Approving Payments.